Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04755283 |
|---|---|
| Brief Title: | Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71) |
| First Submitted : | February 11, 2021 |
| First Submitted that Met QC Criteria : | February 11, 2021 |
| First Posted : | February 16, 2021 |
| Last Update Submitted that Met QC Criteria : | March 15, 2024 |
| Last Update Posted : | March 18, 2024 |